MedPath
NMPA Approval

Erlotinib Hydrochloride Tablets

国药准字HJ20160392

November 17, 2020

H20160392

Drug Information

盐酸厄洛替尼片

特罗凯

片剂

100mg

化学药品

November 17, 2020

November 16, 2025

Company Information

Applicant Company

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany

Manufacturing Company

Via Carnevale 1, 20054 Segrate (MI), Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸厄洛替尼片 - NMPA 批准文号 | MedPath